LIRAGLUTIDE 6 mg/mL
LIRAGLUTIDE · INJECTION, SOLUTION · Orbicular Pharmaceutical Technologies Private Limited
No Recall History
Plain English
LIRAGLUTIDE is a injection, solution containing liraglutide at 6 mg/mL, taken subcutaneous. Manufactured by Orbicular Pharmaceutical Technologies Private Limited.
Key Facts
- Brand Name
- LIRAGLUTIDE
- Generic Name
- LIRAGLUTIDE
- NDC Code (Product)
81607-018- Manufacturer
- Orbicular Pharmaceutical Technologies Private Limited
- Strength
- 6 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- ANDA217590
- Drug Class
- GLP-1 Receptor Agonist [EPC]
- Marketing Start
- 01/21/2026
Recall History
No Recall HistoryFrequently Asked Questions
What is LIRAGLUTIDE used for?
LIRAGLUTIDE contains LIRAGLUTIDE. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is LIRAGLUTIDE a controlled substance?
LIRAGLUTIDE is not classified as a controlled substance by the DEA.
What is the generic name for LIRAGLUTIDE?
The generic name for LIRAGLUTIDE is LIRAGLUTIDE. There are 12 other brand versions of LIRAGLUTIDE.
What is the NDC code for LIRAGLUTIDE 6 mg/mL?
The NDC (National Drug Code) for LIRAGLUTIDE 6 mg/mL is 81607-018, listed by Orbicular Pharmaceutical Technologies Private Limited.